Send to

Choose Destination
Oncoscience. 2018 Aug 22;5(9-10):254-255. doi: 10.18632/oncoscience.458. eCollection 2018 Sep.

Targeting PIM kinases to oppose hypoxia-mediated therapeutic resistance.

Author information

University of Arizona Cancer Center, Department of Cellular and Molecular Medicine, University of Arizona, Levy Cancer Center, Tucson, Arizona 85724 USA.


Nrf2; PIM kinase; angiogenesis; hypoxia; therapeutic resistance

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no potential conflicts of interest.

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center